GeneDx Holdings (WGS) Shares Outstanding (2020 - 2026)

GeneDx Holdings (WGS) has reported Shares Outstanding (Entity) for 7 consecutive years, with $29.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.81% year-over-year to $29.8 million in Q2 2026; TTM through Jun 2026 was $29.8 million, a 3.81% increase from a year earlier, with the FY2025 full-year figure at $29.2 million, up 4.39% from the prior year.
• Shares Outstanding (Entity) was $29.8 million for Q2 2026 at GeneDx Holdings, roughly flat from $29.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $245.2 million in Q1 2022 and troughed at $20.1 million in Q1 2023.
• A 5-year average of $45.9 million and a median of $28.6 million in 2025 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 847.68% in 2022 and sank 91.82% in 2023, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $66.4 million in 2022, then sank by 60.88% to $26.0 million in 2023, then increased by 7.84% to $28.0 million in 2024, then rose by 4.39% to $29.2 million in 2025, then rose by 1.91% to $29.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $29.8 million (Q2 2026), $29.7 million (Q1 2026), and $29.2 million (Q4 2025), per Business Quant data.